Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Glaxosmithkline Fundamentals

Company Name GlaxoSmithKline Last Updated 02 Jun 2020
Industry Health Care Sector Pharmaceuticals
Shares in Issue (m) 5,017.17 Market Cap (£m) 82,813.47
PE Ratio 17.58 Div per Share (p) 80.00
Div Yield 4.85 Div Cover 1.17
EPS 93.90 EPS Growth (%) 27.41
PEG 0.64 DPS Growth (%) 0.00
Debt Ratio 67.01 Debt Equity Ratio 0.61
Net Gearing 71.06 Gross Gearing 76.97
Asset Equity Ratio 4.34 Cash Equity Ratio 25.64
Quick Ratio 0.56 Current Ratio 0.81
Price To Book Value 4.51 ROCE 11.18

Glaxosmithkline Dividends

Type Ex-Date Pay Date Currency Net Dividend Year Total
Q1 Dividend 14 May 2020 09 Jul 2020 GBX 19.00
H2 Dividend 20 Feb 2020 09 Apr 2020 GBX 23.00 80.00
Q3 Dividend 14 Nov 2019 09 Jan 2020 GBX 19.00
H1 Dividend 08 Aug 2019 10 Oct 2019 GBX 19.00
Q1 Dividend 16 May 2019 11 Jul 2019 GBX 19.00
H2 Dividend 21 Feb 2019 11 Apr 2019 GBX 23.00 80.00
Q3 Dividend 15 Nov 2018 10 Jan 2019 GBX 19.00
H1 Dividend 09 Aug 2018 11 Oct 2018 GBX 19.00
Q1 Dividend 10 May 2018 12 Jul 2018 GBX 19.00
H2 Dividend 22 Feb 2018 12 Apr 2018 GBX 23.00 80.00
Q3 Dividend 09 Nov 2017 11 Jan 2018 GBX 19.00
H1 Dividend 10 Aug 2017 12 Oct 2017 GBX 19.00
Q1 Dividend 11 May 2017 13 Jul 2017 GBX 19.00
H2 Dividend 23 Feb 2017 13 Apr 2017 GBX 23.00 80.00
Q3 Dividend 03 Nov 2016 12 Jan 2017 GBX 19.00
H1 Dividend 11 Aug 2016 13 Oct 2016 GBX 19.00
Q1 Dividend 12 May 2016 14 Jul 2016 GBX 19.00
Special Dividend 18 Feb 2016 14 Apr 2016 GBX 20.00
H2 Dividend 18 Feb 2016 14 Apr 2016 GBX 23.00 80.00
Q3 Dividend 12 Nov 2015 14 Jan 2016 GBX 19.00
H1 Dividend 13 Aug 2015 01 Oct 2015 GBX 19.00
Q1 Dividend 14 May 2015 09 Jul 2015 GBX 19.00

Glaxosmithkline Company Financials

Assets (£m) 2019 2018 2017
Tangible Assets 10,348 11,058 10,860
Intangible Assets 41,517 22,991 23,296
Investments 8,336 7,090 6,318
Total Fixed Assets 60,201 41,139 40,474
Stocks 5,947 5,476 5,557
Debtors 7,202 6,423 6,000
Cash & Equivalents 4,707 3,874 3,833
Other Assets 1,635 1,154 517
Total Assets 79,692 58,066 56,381
Liabilities (£m) 2019 2018 2017
Creditors within 1 year 24,050 22,491 26,569
Creditors after 1 year 37,285 31,903 26,323
Other Liabilities 0 0 0
Total Liabilities 61,335 54,394 52,892
Net assets 18,357 3,672 3,489
Equity (£m) 2019 2018 2017
Called up share capital 1,346 1,345 1,343
Share Premium 3,174 3,091 3,019
Profit / Loss 6,221 4,800 3,525
Other Equity 2,355 2,061 2,047
Preference & Minorities 6,373 -688 3,557
Total Capital Employed 18,357 3,672 3,489
Ratios 2019 2018 2017
Debt Ratio 67.01 89.68 88.30
Debt-to-Equity 0.61 0.59 0.50
Net Gearing 71.06 87.00 87.01
Gross Gearing 76.97 93.68 93.81
Assets / Equity 4.34 15.81 16.16
Cash / Equity 25.64 105.50 109.86
EPS 93.90 73.70 31.40
Cash Flow (£m) 2019 2018 2017
Cash from operating activities 8,020 8,421 6,918
Cashflow before financing 2,666 6,868 5,475
Increase in Cash 826 479 -905
Income (£m) 2019 2018 2017
Turnover 33,754 30,821 30,186
Cost of sales 11,863 10,241 10,342
Gross Profit 21,891 20,580 19,844
Operating Profit 6,961 5,483 4,087
Pre-Tax profit 6,221 4,800 3,525
Profit / Loss for the year 1,346 1,345 1,343

Glaxosmithkline Company Background

Sector Pharmaceuticals
Activities GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment. Headquartered in the UK and with operations based in the US, the new company is one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market. GSK also has leadership in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio of oncology products. The company also has a Consumer Healthcare portfolio comprising over-the-counter (OTC) medicines, oral care products and nutritional healthcare drinks, all of which are among the market leaders. GSK has over 100,000 employees worldwide. Of these, over 40,000 are in sales and marketing, the largest sales force in the industry. Around 35,000 employees work at 82 manufacturing sites in 37 countries and over 15,000 are in R&D. GSK R&D is based at 24 sites in 11 countries. The company has a leading position in genomics/genetics and new drug discovery technologies. The GSK R&D budget is about £2.8bn/$5bn.
Latest Interim Date 24 Jul 2019
Latest Fiscal Year End Date 05 Feb 2020

Glaxosmithkline Directors

Appointed Director Position
01 Jan 2017 Emma Natasha Walmsley Chief Executive Officer
14 Jan 2019 Iain James Mackay Chief Financial Officer
01 Jan 2018 Dr Hal Barron Chief Scientific Officer
01 Sep 2019 Jonathan Richard Symonds Non-Executive Chairman
01 May 2020 Charles A Bancroft Non-Executive Director
01 Jan 2015 Urs Rohner Non-Executive Director
01 Apr 2011 Judith Carol Lewent Non-Executive Director
01 Sep 2017 Dr Laurie Hollis Glimcher Non-Executive Director
01 Jan 2016 Dr Jesse Goodman Non-Executive Director
01 Jul 2012 Lynn Laverty Elsenhans Non-Executive Director
01 Jul 2016 Dr Vivienne Cox Non-Executive Director
01 Sep 2015 Manvinder Singh Banga Non-Executive Director

Glaxosmithkline Contact Details

Company Name GlaxoSmithKline
Company Address 980 Great West Road, Brentford, Middlesex TW8 9GS.
Company Telephone +44 (0)20 8047 5000
Company Website http://www.gsk.com/

Glaxosmithkline Advisors

Auditor Name PricewaterhouseCoopers LLP
Auditor Address 1 Embankment Place, London WC2N 6RH.
Auditor Website http://www.pwc.co.uk/
Auditor Telephone +44(0) 20 7583 5000
Registrar Name Equiniti
Registrar Address Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA.
Registrar Website http://www.equiniti.com/
Registrar Telephone 0871 384 2030
Broker Name Jefferies Hoare Govett
Broker Address Vintners Place, 68 Upper Thames Street, London EC4V 3BJ.
Broker Website http://www.jefferies.com/
Broker Telephone +44 (0)20 7029 8000
Adviser Name n/a
Adviser Address n/a
Adviser Website n/a
Adviser Telephone n/a
Solicitor Name n/a
Solicitor Address n/a
Solicitor Website n/a
Solicitor Telephone n/a
Stockbroker Name n/a
Stockbroker Address n/a
Stockbroker Website n/a
Stockbroker Telephone n/a